| Ms Ann Marie Meadowbrook, MS | |
|
1052 Sw 29th, Albany, OR 97321 | |
| (541) 926-8288 | |
| (541) 926-7234 |
| Full Name | Ms Ann Marie Meadowbrook |
|---|---|
| Gender | Female |
| Speciality | Psychologist |
| Location | 1052 Sw 29th, Albany, Oregon |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184787939 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | 5051 (Oregon) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Ann Marie Meadowbrook, MS 1052 Sw 29th, Albany, OR 97321 Ph: (541) 926-8288 | Ms Ann Marie Meadowbrook, MS 1052 Sw 29th, Albany, OR 97321 Ph: (541) 926-8288 |
News Archive
Approximately 50,000 potassium iodide tablets have been donated by Nukepills.com to Tokushukai Hospital in Tokyo, Japan for immediate distribution to those affected by Japan's nuclear reactor crisis.
The National Multiple Sclerosis Society awarded Victoria Leavitt, PhD, a $619,618 grant to study predictors of memory decline in MS. Dr. Leavitt, a scientist in Neuropsychology and Neuroscience Research at Kessler Foundation, will use functional magnetic resonance imaging to evaluate a brain marker with predictive value for memory decline.
In a New England Journal of Medicine perspective, experts from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, and the World Health Organization Collaborating Centre for Reference and Research on Influenza in Melbourne discuss how the process of preparing seasonal influenza vaccines in eggs may contribute to their limited effectiveness.
Quantum Health, the leader in care coordination and consumer navigation, announced today that it has achieved a major business milestone, making 5,497,028 connections, helping 779,470 consumers and providers more effectively navigate the complex healthcare system.
Schering-Plough Corporation has announced that it has extended to stage two an ongoing Phase II clinical study with vicriviroc, its investigational CCR5 antagonist, for use in first-line therapy of adult treatment-naive HIV-infected patients with R5-type virus only. In this study, vicriviroc is being evaluated in a novel nucleoside-sparing regimen that is designed to provide additional options for treatment-naive patients in a once daily regimen, while preserving other drug classes for subsequent lines of treatment.
› Verified 5 days ago
Linda Renee Bockheim, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 425 2nd Ave Sw Ste 204, Albany, OR 97321 Phone: 541-248-9153 | |
Amy Leroy, PHD Psychologist Medicare: Medicare Enrolled Practice Location: 534 Pleasant View Way Nw Ste 200, Albany, OR 97321 Phone: 541-812-5760 | |
Alexandra Lee Koenig, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1700 Geary St Se Ste 200, Albany, OR 97322 Phone: 541-812-5570 | |
Michael Boggess, PH.D. Psychologist Medicare: Medicare Enrolled Practice Location: 534 Pleasant View Way Nw Ste 300, Albany, OR 97321 Phone: 541-812-3323 | |
Dr. Jane Irby Allen, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 445 3rd Ave Sw, Albany, OR 97321 Phone: 541-967-3866 | |
Sergio Alejandro Sanchez Carrasco, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 445 3rd Ave Sw, Albany, OR 97321 Phone: 541-967-3866 |